Signal 4: Say goodbye to misunderstanding instructions!
According to a study in Therapeutics and Clinical Risk Management, more than 40% of patients experience health risks by misunderstanding, forgetting, or ignoring advice from their clinician (Walsh, 2007). So how can we make sure the patients not only understand their treatment plan but actually follow through with it in their daily life? Noteworth makes significant headway.
The virtual care model provided by the Noteworth has two key components: one is bundling health diagnostic hardware together, and the another is digital patient instructions. Noteworth matches clinician orders and instructions for individual patients to kits of connected devices shipped directly to patients’ doors. After individuals use devices, the clinician can order any data type that they’d like to see for the patient, like blood pressure, blood glucose, body weight, heart rate, and more. Then, the clinician can now add specific instructions and notes for the patient about how they should collect that data with just a few clicks. (like “Take your blood pressure once a day upon waking.”), so patients now have a daily “to-do list” that is automatically created based on their personal care instructions and get a comprehensive look at their clinician’s expectations of them.
Personally, I think some further applications can be based on this digital. For people who have chronic diseases, they always need to test their health indexes regularly. However, a problem in collecting those health diagnostic data is that it’s always a manual process and the data is easy to vanish. For example, most diabetics manually take their own blood sugar samples every day, while the results just used for daily checking and then through away. Therefore, this model can seamlessly upload the key health data to the cloud, analyzed by the software to generate simple health report, and then communicated back to the patient’s physician, thus the trend of health conditions can be predicted and doctors can detect the problems with actionable recommendations timely.
Reference：Walsh, G. (2007). Editorial. Therapeutics And Clinical Risk Management, 3(1), 1–2. doi: 10.2147/tcrm.2007.3.1.1
